Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
288 participants
INTERVENTIONAL
2020-12-23
2021-06-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with Artificial intelligence assistant system
The experiment group would receive the training with the help of artificial intelligence assistant system in addition to the common training. The system is an non-invasive AI system which could help the endoscopists to diagnosis and monitor the blind spot during the gastroscope.
Artificial intelligence assistant system
The intervention is the use of the artificial intelligence assistant system in addition to the common training. The system is an non-invasive AI system which could help the endoscopists to diagnosis and monitor the blind spot during the gastroscope.
without Artificial intelligence assistant system
The control group would receive the training without the help of artificial intelligence assistant system. That is, they would receive the common training process.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artificial intelligence assistant system
The intervention is the use of the artificial intelligence assistant system in addition to the common training. The system is an non-invasive AI system which could help the endoscopists to diagnosis and monitor the blind spot during the gastroscope.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. After qualified medical education and obtained the Certificate of Chinese medical practitioner;
Exclusion Criteria
2. Doctors without qualified medical education and didn't obtaine the Certificate of Chinese medical practitioner;
3. The researcher believes that the subjects are not suitable for participating in clinical trials.
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Renmin Hospital of Wuhan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Honggang W Yu, Doctor
Role: PRINCIPAL_INVESTIGATOR
Renmin Hospital of Wuhan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renmin Hospital of Wuhan University
Wuhan, , China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Huang L, Liu J, Wu L, Xu M, Yao L, Zhang L, Shang R, Zhang M, Xiong Q, Wang D, Dong Z, Xu Y, Li J, Zhu Y, Gong D, Wu H, Yu H. Impact of Computer-Assisted System on the Learning Curve and Quality in Esophagogastroduodenoscopy: Randomized Controlled Trial. Front Med (Lausanne). 2021 Dec 14;8:781256. doi: 10.3389/fmed.2021.781256. eCollection 2021.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA-19-003-19
Identifier Type: -
Identifier Source: org_study_id